Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for ...

An oncologist tells PEOPLE about the innovative cancer treatment that extended the former president’s life as he celebrates ...

In a follow-up study, researchers compared cancer immunotherapy in mice, using either single or double immune responses. And ...

WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for ...

Thanks to early detection through widespread screening and dramatic breakthroughs in immunotherapy and other cancer ...

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) ...

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...